Multimodality vendor Picker International of Cleveland has formed a new oncology division to integrate the company’s various technologies into new advanced treatment planning systems. Picker already has a 70% share of the treatment planning market
Multimodality vendor Picker International of Cleveland has formed a new oncology division to integrate the companys various technologies into new advanced treatment planning systems. Picker already has a 70% share of the treatment planning market with its Acqsim 3-D CT treatment planning system, and Picker hopes to incorporate other modalities, such as x-ray, MRI, and ultrasound, into its treatment planning offerings.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.